[Clinical trial of Pilogel HS made by Alcon].
The authors give an account on the results of clinical tests of the anti-glaucomatous preparation PILOGEL HS of ALCON Co. The drug replaced in all groups of patients reliably 1-3% Pilocarpine administered three times a day, as regards its effect on intraocular tension. Its great practical advantage is that the effect is achieved after a single administration per 24 hours (at night). In particular patients in their productive age appreciate this advantage. The preparation was included in the import plan.
Katedra chorob ocních LF UP, Olomouc.
M
M
Vymazal
Z
Z
Válková
M
M
Poláchová
E
E
Dokonalová
H
H
Dragounová
J
J
Jezdinský
D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D005782:Gels; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010862:Pilocarpine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use
D005782:Gels; D010862:Pilocarpine; D013999:Timolol
Klinické zkousení prípravku Pilogel HS firmy Alcon.